Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system

YP de Coaña, A Choudhury, R Kiessling - Trends in molecular medicine, 2015 - cell.com
Immune checkpoint receptors are crucial molecules for fine-tuning immune responses.
Checkpoint signaling dampens T cell activation to avoid autoimmunity and the destructive …

Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system

YP de Coaña, A Choudhury, R Kiessling - Trends in Molecular Medicine, 2015 - cell.com
Immune checkpoint receptors are crucial molecules for fine-tuning immune responses.
Checkpoint signaling dampens T cell activation to avoid autoimmunity and the destructive …

Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system.

Y Pico de Coaña, A Choudhury… - Trends in Molecular …, 2015 - europepmc.org
Immune checkpoint receptors are crucial molecules for fine-tuning immune responses.
Checkpoint signaling dampens T cell activation to avoid autoimmunity and the destructive …

Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system

YP de Coaña, A Choudhury… - Trends in molecular …, 2015 - pubmed.ncbi.nlm.nih.gov
Immune checkpoint receptors are crucial molecules for fine-tuning immune responses.
Checkpoint signaling dampens T cell activation to avoid autoimmunity and the destructive …

Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system

YP de Coaña, A Choudhury, R Kiessling - Trends in Molecular Medicine, 2015 - infona.pl
Immune checkpoint receptors are crucial molecules for fine-tuning immune responses.
Checkpoint signaling dampens T cell activation to avoid autoimmunity and the destructive …

[引用][C] Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system

YP de Coaña, A Choudhury, R Kiessling - Trends in Molecular Medicine, 2015 - cir.nii.ac.jp
Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system

YP de Coaña, A Choudhury, R Kiessling - Trends in Molecular Medicine, 2015 - Elsevier
Highlights•Immune checkpoints dampen T cell activation, avoiding excessive immune
responses.•CTLA-4 and PD-1 are currently the two most clinically relevant immune …